<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; now</title>
	<atom:link href="http://www.tapanray.in/tag/now/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Maintaining Supply Chain Security in pharmaceuticals: The need is now more than ever before.</title>
		<link>http://www.tapanray.in/maintaining-supply-chain-security-in-pharmaceuticals-the-need-is-now-more-than-ever-before/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=maintaining-supply-chain-security-in-pharmaceuticals-the-need-is-now-more-than-ever-before</link>
		<comments>http://www.tapanray.in/maintaining-supply-chain-security-in-pharmaceuticals-the-need-is-now-more-than-ever-before/#comments</comments>
		<pubDate>Mon, 26 Sep 2011 00:00:13 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[before]]></category>
		<category><![CDATA[chain]]></category>
		<category><![CDATA[distribution]]></category>
		<category><![CDATA[ever]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[global]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[logistics]]></category>
		<category><![CDATA[Maintaining]]></category>
		<category><![CDATA[more]]></category>
		<category><![CDATA[need]]></category>
		<category><![CDATA[now]]></category>
		<category><![CDATA[outsourcing]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[SCS]]></category>
		<category><![CDATA[Security]]></category>
		<category><![CDATA[Supply]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[than]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=197</guid>
		<description><![CDATA[In today’s globalized economy maintaining Supply Chain Security (SCS), especially in the pharmaceutical sector across the world, is more critical than ever before. We have many instances of SCS being seriously breached, not only in the emerging pharmaceutical markets but &#8230; <a href="http://www.tapanray.in/maintaining-supply-chain-security-in-pharmaceuticals-the-need-is-now-more-than-ever-before/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/maintaining-supply-chain-security-in-pharmaceuticals-the-need-is-now-more-than-ever-before/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The top 10 environment polluters of the world should now transform themselves into the top 10 saviours of the world from the disaster of Climate Change</title>
		<link>http://www.tapanray.in/the-top-10-environment-polluters-of-the-world-should-now-transform-themselves-into-the-top-10-saviours-of-the-world-from-the-disaster-of-climate-change/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-top-10-environment-polluters-of-the-world-should-now-transform-themselves-into-the-top-10-saviours-of-the-world-from-the-disaster-of-climate-change</link>
		<comments>http://www.tapanray.in/the-top-10-environment-polluters-of-the-world-should-now-transform-themselves-into-the-top-10-saviours-of-the-world-from-the-disaster-of-climate-change/#comments</comments>
		<pubDate>Thu, 24 Dec 2009 00:30:51 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[10]]></category>
		<category><![CDATA[Change]]></category>
		<category><![CDATA[Climate]]></category>
		<category><![CDATA[disaster]]></category>
		<category><![CDATA[environment]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[From]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[into the]]></category>
		<category><![CDATA[nations]]></category>
		<category><![CDATA[now]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[polluters]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[saviours]]></category>
		<category><![CDATA[Should]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[themselves]]></category>
		<category><![CDATA[top]]></category>
		<category><![CDATA[transform]]></category>
		<category><![CDATA[United]]></category>
		<category><![CDATA[USA]]></category>
		<category><![CDATA[World]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=688</guid>
		<description><![CDATA[Global awareness dawned early: After World War the second, various types of atmospheric pollution started drawing increasing public attention in the western world, both in the USA and Europe. In Europe, the incidence of London’s ‘Great Smog’ in 1952 initiated the process &#8230; <a href="http://www.tapanray.in/the-top-10-environment-polluters-of-the-world-should-now-transform-themselves-into-the-top-10-saviours-of-the-world-from-the-disaster-of-climate-change/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/the-top-10-environment-polluters-of-the-world-should-now-transform-themselves-into-the-top-10-saviours-of-the-world-from-the-disaster-of-climate-change/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Will the ‘Bayer–Cipla case’ now put the ‘Bolar Provision’ under judicial scrutiny?</title>
		<link>http://www.tapanray.in/will-the-bayer-cipla-case-now-put-the-bolar-provision-under-judicial-scrutiny/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=will-the-bayer-cipla-case-now-put-the-bolar-provision-under-judicial-scrutiny</link>
		<comments>http://www.tapanray.in/will-the-bayer-cipla-case-now-put-the-bolar-provision-under-judicial-scrutiny/#comments</comments>
		<pubDate>Thu, 22 Oct 2009 01:00:17 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Bayer]]></category>
		<category><![CDATA[Bayer–Cipla]]></category>
		<category><![CDATA[Bolar]]></category>
		<category><![CDATA[Case]]></category>
		<category><![CDATA[Cipla]]></category>
		<category><![CDATA[IP]]></category>
		<category><![CDATA[IPR]]></category>
		<category><![CDATA[judicial]]></category>
		<category><![CDATA[linkage]]></category>
		<category><![CDATA[Nexavar]]></category>
		<category><![CDATA[now]]></category>
		<category><![CDATA[Patent]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Provision]]></category>
		<category><![CDATA[put]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[scrutiny]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[under]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=748</guid>
		<description><![CDATA[To enable the domestic pharmaceutical industry gaining a critical mass and cater to the pressing healthcare needs of the nation, in 1970 product patent act was abolished by the government of India. This immensely helped the domestic companies to launch &#8230; <a href="http://www.tapanray.in/will-the-bayer-cipla-case-now-put-the-bolar-provision-under-judicial-scrutiny/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/will-the-bayer-cipla-case-now-put-the-bolar-provision-under-judicial-scrutiny/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Is the world now moving towards ‘Global Patent’ system?</title>
		<link>http://www.tapanray.in/is-the-world-now-moving-towards-global-patent-system-2/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=is-the-world-now-moving-towards-global-patent-system-2</link>
		<comments>http://www.tapanray.in/is-the-world-now-moving-towards-global-patent-system-2/#comments</comments>
		<pubDate>Mon, 11 May 2009 01:00:09 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[global]]></category>
		<category><![CDATA[is]]></category>
		<category><![CDATA[moving]]></category>
		<category><![CDATA[now]]></category>
		<category><![CDATA[Patent]]></category>
		<category><![CDATA[PCT]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[system]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[towards]]></category>
		<category><![CDATA[World]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=892</guid>
		<description><![CDATA[A brief background: In June 19, 1970 an International patent law treaty was signed in Washington, initially with 18 contracting states. This treaty is called ‘The Patent Co-operation Treaty’ (PCT), which came into force on January 24, 1978 and was &#8230; <a href="http://www.tapanray.in/is-the-world-now-moving-towards-global-patent-system-2/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/is-the-world-now-moving-towards-global-patent-system-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>R&amp;D and Protection of IPR related to Pharma sector, are now the responsibilities of the Department of Pharmaceuticals (DoP) – a quick look at the initiatives taken by the department.</title>
		<link>http://www.tapanray.in/rd-and-protection-of-ipr-related-to-pharma-sector-are-now-the-responsibilities-of-the-department-of-pharmaceuticals-dop-a-quick-look-at-the-initiatives-taken-by-the-department/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=rd-and-protection-of-ipr-related-to-pharma-sector-are-now-the-responsibilities-of-the-department-of-pharmaceuticals-dop-a-quick-look-at-the-initiatives-taken-by-the-department</link>
		<comments>http://www.tapanray.in/rd-and-protection-of-ipr-related-to-pharma-sector-are-now-the-responsibilities-of-the-department-of-pharmaceuticals-dop-a-quick-look-at-the-initiatives-taken-by-the-department/#comments</comments>
		<pubDate>Mon, 09 Mar 2009 14:00:44 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[and]]></category>
		<category><![CDATA[are]]></category>
		<category><![CDATA[at]]></category>
		<category><![CDATA[by]]></category>
		<category><![CDATA[Department]]></category>
		<category><![CDATA[DoP]]></category>
		<category><![CDATA[Government]]></category>
		<category><![CDATA[initiatives]]></category>
		<category><![CDATA[IPR]]></category>
		<category><![CDATA[look]]></category>
		<category><![CDATA[now]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Protection]]></category>
		<category><![CDATA[Quick]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[related]]></category>
		<category><![CDATA[responsibilities]]></category>
		<category><![CDATA[sector]]></category>
		<category><![CDATA[taken]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[to]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=947</guid>
		<description><![CDATA[On July 2, 2008, the Cabinet Secretariat of the Government of India notified creation of a new department to be known as the Department of Pharmaceuticals (DoP) under the Ministry of Chemicals and Fertilisers with an objective to have a &#8230; <a href="http://www.tapanray.in/rd-and-protection-of-ipr-related-to-pharma-sector-are-now-the-responsibilities-of-the-department-of-pharmaceuticals-dop-a-quick-look-at-the-initiatives-taken-by-the-department/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/rd-and-protection-of-ipr-related-to-pharma-sector-are-now-the-responsibilities-of-the-department-of-pharmaceuticals-dop-a-quick-look-at-the-initiatives-taken-by-the-department/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The heated debate on WHO IMPACT definition of Counterfeit Drugs is now on a ‘pause’ – A time to evaluate the reasons for supporting and opposing it.</title>
		<link>http://www.tapanray.in/the-heated-debate-on-who-impact-definition-of-counterfeit-drugs-is-now-on-a-pause-a-time-to-evaluate-the-reasons-for-supporting-and-opposing-it/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-heated-debate-on-who-impact-definition-of-counterfeit-drugs-is-now-on-a-pause-a-time-to-evaluate-the-reasons-for-supporting-and-opposing-it</link>
		<comments>http://www.tapanray.in/the-heated-debate-on-who-impact-definition-of-counterfeit-drugs-is-now-on-a-pause-a-time-to-evaluate-the-reasons-for-supporting-and-opposing-it/#comments</comments>
		<pubDate>Fri, 06 Mar 2009 15:15:50 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[a]]></category>
		<category><![CDATA[a pause]]></category>
		<category><![CDATA[and]]></category>
		<category><![CDATA[confiscation]]></category>
		<category><![CDATA[Counterfeit]]></category>
		<category><![CDATA[debate]]></category>
		<category><![CDATA[definition]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[EU]]></category>
		<category><![CDATA[evaluate]]></category>
		<category><![CDATA[for]]></category>
		<category><![CDATA[generics]]></category>
		<category><![CDATA[heated]]></category>
		<category><![CDATA[IMPACT]]></category>
		<category><![CDATA[is]]></category>
		<category><![CDATA[now]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[on]]></category>
		<category><![CDATA[opposing]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[reasons]]></category>
		<category><![CDATA[supporting]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[time]]></category>
		<category><![CDATA[to]]></category>
		<category><![CDATA[WHO]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=950</guid>
		<description><![CDATA[The World Health Organisation (WHO), in December 2008, proposed the following new definition, as prepared by the International Medical Products Anti-Counterfeiting Taskforce (IMPACT):“A medical product is counterfeit when there is a false representation in relation to its identity and/or source. &#8230; <a href="http://www.tapanray.in/the-heated-debate-on-who-impact-definition-of-counterfeit-drugs-is-now-on-a-pause-a-time-to-evaluate-the-reasons-for-supporting-and-opposing-it/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/the-heated-debate-on-who-impact-definition-of-counterfeit-drugs-is-now-on-a-pause-a-time-to-evaluate-the-reasons-for-supporting-and-opposing-it/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
